UNSPSC 51321901: Bezafibrate

This classification denotes an anti-lipidemic agent with the molecular formula C19H20ClNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y9449Q51XH, chemically known as propionic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl- but generally known as bezafibrate, which bears US NIH Compound Identifier 39042. European Medicines Agency schedules Bezafibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05810MIG. The term BEZAFIBRATE is an International Non-Proprietary Name.

UNSPSC 51321901 Bezafibrate is a Commodity code for a specific generic pharmaceutical ingredient used in cardiovascular and lipid-management therapies. State and local governments procure bezafibrate and related pharmaceuticals primarily through emergency medical services, public health agencies, and cooperative purchasing alliances that aggregate demand across multiple jurisdictions and facilities. The work involves supplying FDA-compliant, manufacturer-certified medications with specified shelf-life requirements, often bundled with broader pharmaceutical portfolios rather than as stand-alone line items. Issuing bodies include municipal fire and rescue services (such as Tampa Fire Rescue), state health and human services departments, and multistate cooperative purchasing organizations that serve state agencies, counties, cities, and other local entities. Solicitations typically mandate compliance with Good Manufacturing Practices, Drug Supply Chain Security Act standards, OSHA safety documentation, and federal accessibility requirements, with pricing models based on net cost, wholesale acquisition cost minus discounts, or fixed pricing structures negotiated through authorized wholesalers.

Recent activity centers on Florida and Texas, with multistate cooperative vehicles based in Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 (posted April 24, 2026; due April 8, 2026) for Advanced Life Support Medications including epinephrine, labetalol, adenosine, and diltiazem to supply Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market designation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) to establish multi-vendor contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, with evaluation weighted heavily (75 percent) on price competitiveness and requiring distribution through three authorized wholesalers. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels, signaling emerging state interest in alternative procurement models for pharmaceutical supply.